Level-I evidence for prognostic and predictive impact of uPA and PAI-1 in node-negative breast cancer provided by second scheduled analysis of multicenter Chemo-N0 therapy trial. - Harbeck,N.; Meisner,C.; Prechtl,A.; Untch,M.; Selbmann,H.K.; Sweep,C.GJ.; Graeff,H.; Schmitt,M.; Jänicke,F.; Thomssen,C. (Breast Cancer Res Treat, 2001)